Evicenter
P&T meetings

QTORIN rapamycin 3.9 percent gel

Microcystic lymphatic malformations

Regulatory submission
NDA submitted August 2026
78 sources

Section 6 of 6

References

78 sources

  1. Abtahi-Naeini et al. (2025) (opens in a new tab)
  2. Adams et al. (2016) (opens in a new tab)
  3. Adams et al. (2016) (opens in a new tab)
  4. Allemang-Trivalle et al. (2026) (opens in a new tab)
  5. Badia et al. (2020) (opens in a new tab)
  6. Balakrishnan et al. (2012) (opens in a new tab)
  7. Bonilla-Velez et al. (2025) (opens in a new tab)
  8. Cai et al. (2023) (opens in a new tab)
  9. Çalışkan et al. (2018) (opens in a new tab)
  10. Canaud et al. (2021) (opens in a new tab)
  11. Cheng et al. (2017) (opens in a new tab)
  12. ClinicalTrials.gov NCT05050149 (opens in a new tab)
  13. Cui et al. (2026) (opens in a new tab)
  14. Dodds et al. (2020) (opens in a new tab)
  15. FDA Orphan Drug Designations and Approvals (2021) (opens in a new tab)
  16. Gallagher et al. (2022) (opens in a new tab)
  17. García-Montero et al. (2017) (opens in a new tab)
  18. García-Montero et al. (2019) (opens in a new tab)
  19. Ghaffarpour et al. (2019) (opens in a new tab)
  20. Ghaffarpour et al. (2022) (opens in a new tab)
  21. Goldenberg et al. (2025) (opens in a new tab)
  22. Gu and Sebaratnam (2024) (opens in a new tab)
  23. Hollman et al. (2026) (opens in a new tab)
  24. Huerta et al. (2024) (opens in a new tab)
  25. ICH GCP NCT06239480 (opens in a new tab)
  26. Ivars and Redondo (2017) (opens in a new tab)
  27. Jinnin et al. (2025) (opens in a new tab)
  28. Kalwani and Rockson (2021) (opens in a new tab)
  29. Kamireddy et al. (2026) (opens in a new tab)
  30. Kinoshita et al. (2026) (opens in a new tab)
  31. Kirkham et al. (2015) (opens in a new tab)
  32. Kitchloo et al. (2024) (opens in a new tab)
  33. Lapa and Sandre (2026) (opens in a new tab)
  34. Le Sage et al. (2018) (opens in a new tab)
  35. Leboulanger et al. (2023) (opens in a new tab)
  36. Leboulanger et al. (2023) (opens in a new tab)
  37. Leducq et al. (2019) (opens in a new tab)
  38. Mäkinen et al. (2021) (opens in a new tab)
  39. Marchand et al. (2022) (opens in a new tab)
  40. Maruani et al. (2021) (opens in a new tab)
  41. Palvella Therapeutics (opens in a new tab)
  42. Palvella Therapeutics (opens in a new tab)
  43. Palvella Therapeutics (opens in a new tab)
  44. Palvella Therapeutics (opens in a new tab)
  45. Palvella Therapeutics (2023) (opens in a new tab)
  46. Palvella Therapeutics (2023) (opens in a new tab)
  47. Palvella Therapeutics (2023) (opens in a new tab)
  48. Palvella Therapeutics (2025) (opens in a new tab)
  49. Palvella Therapeutics (2025) (opens in a new tab)
  50. Palvella Therapeutics (2026) (opens in a new tab)
  51. Palvella Therapeutics (2026) (opens in a new tab)
  52. Palvella Therapeutics (2026) (opens in a new tab)
  53. Palvella Therapeutics (2026) (opens in a new tab)
  54. Palvella Therapeutics (2026) (opens in a new tab)
  55. Palvella Therapeutics (2026) (opens in a new tab)
  56. Palvella Therapeutics (2026) (opens in a new tab)
  57. Palvella Therapeutics (2026) (opens in a new tab)
  58. Palvella Therapeutics (2026) (opens in a new tab)
  59. Palvella Therapeutics corporate presentation (2026) (opens in a new tab)
  60. Palvella Therapeutics Form 10-K (2025) (opens in a new tab)
  61. Palvella Therapeutics Form 10-K (2026) (opens in a new tab)
  62. Palvella Therapeutics Form 10-Q (2026) (opens in a new tab)
  63. Palvella Therapeutics ISSVA presentation (2026)
  64. Palvella Therapeutics presentation (2026) (opens in a new tab)
  65. PeDRA (2024) (opens in a new tab)
  66. Saibene et al. (2023) (opens in a new tab)
  67. Seront et al. (2023) (opens in a new tab)
  68. Seront et al. (2026) (opens in a new tab)
  69. Teng et al. (2023) (opens in a new tab)
  70. Teng et al. (2024) (opens in a new tab)
  71. Teng et al. (2025) (opens in a new tab)
  72. Treat (2026) (opens in a new tab)
  73. Treat et al. (2024) (opens in a new tab)
  74. Vandersteen et al. (2025) (opens in a new tab)
  75. Wiegand et al. (2009) (opens in a new tab)
  76. Xu et al. (2026) (opens in a new tab)
  77. Yonekura et al. (2022) (opens in a new tab)
  78. Zenner et al. (2019) (opens in a new tab)